It is clinically used in primary and secondary Hyperuricemia, especially in patients with hyperuricemia, as well as in patients with renal insufficiency, and in patients with recurrent or chronic gout, as well as in patients with Hyperuricemia. Used in patients with Gouty nephropathy to relieve symptoms and reduce the formation of renal uric acid stones; gout stones; used in uric acid kidney stones and uric acid kidney disease.
Use:Intermediate for Linagliptin
Executive standard:enterprise standard
Assay:≥90%
Exterior:White to yellow solid or powder
Package:25kg/drum